)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Eton Pharmaceuticals (ETON) investor relations material
Eton Pharmaceuticals Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary7 Aug, 2025
Executive summary
Achieved record Q2 2025 revenue of $18.9M, up 108% year-over-year, driven by strong commercial execution and product launches including ALKINDI SPRINKLE, INCRELEX, and GALZIN.
Outperformed expectations with INCRELEX, reaching 100 active patients ahead of target, and advanced multiple pipeline programs.
FDA approval and rapid launch of Candivy/KHINDIVI, plus NDA submission and acceptance for ET600, set up additional near-term growth.
Generated $8M in operating cash flow and $3.1M in adjusted EBITDA, demonstrating profitability and capital strength.
Maintains over $25M in cash as of June 30, 2025, with a post-quarter $4.6M inflow from INCRELEX licensing.
Financial highlights
Q2 2025 revenue was $18.9M, a 108% increase year-over-year, with all growth from product sales.
Adjusted gross profit was $14.1M (75% margin), up from $5.9M (65%) year-over-year; gross profit reported at $11.9M.
Adjusted EBITDA was $3.1M, compared to negative $1.6M in the prior year period.
Net loss narrowed to $2.6M ($0.10/share) from $3.0M ($0.12/share) year-over-year; non-GAAP net income was $1.5M.
Cash and equivalents stood at $25.4M as of June 30, 2025, with $8M operating cash flow in the quarter.
Outlook and guidance
Projected to reach $80M annual revenue run rate in Q3 2025, one quarter ahead of previous guidance.
Full-year 2025 adjusted gross margin expected at ~70%, with a long-term target of 75% by 2028.
Sequential revenue growth to continue, but at a slower pace due to one-time launch effects.
Adjusted G&A expenses expected to remain flat or decline in H2 2025; no significant new SG&A investments planned.
Management expects existing cash and revenues to fund operations and capital expenditures for at least twelve months.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Eton Pharmaceuticals earnings date
Q3 202511 Nov, 2025
Next Eton Pharmaceuticals earnings date
Q3 202511 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. Its lead product candidate is Etonogestrel/Ethinyl Estradiol (ETN/EE) Vaginal Contraceptive System (VCS), an FDA approved Class 4 non-biodegradable contraceptive vaginal ring for the treatment of female contraception. The company was founded in 2013 and is based in Bloomingdale, Illinois.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage